Mandatory reporting of serious adverse drug reactions and medical device incidents by hospitals - Overview

The purpose of this guidance document is to provide hospitals with information that may be useful in achieving compliance with the federal regulatory requirement for hospitals to report serious ADRs and MDIs to Health Canada as outlined in section C.01.020.1 of the Food and Drug Regulations and section 62 of the Medical Device Regulations.

Publisher
Health Canada
Resources
2
Catalogue metadata updated
2021-06-01

Data overview

Formats
HTML
File languages
English, French

Official sources and licences

Resources

Related open data